Francesco Barchiesi Selected Research

Cephalosporinase

2/2022

Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Barchiesi Research Topics

Disease

16	Infections 02/2022 - 09/2004
6	COVID-19 12/2021 - 11/2020
4	Candidemia 01/2021 - 07/2006
4	Aspergillosis 01/2016 - 09/2009
3	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2017
3	Sepsis (Septicemia) 07/2019 - 02/2003
3	Body Weight (Weight, Body) 03/2012 - 01/2007
2	Zygomycosis (Phycomycosis) 10/2010 - 01/2007
2	Candidiasis (Moniliasis) 11/2004 - 12/2002
1	Pneumonia (Pneumonitis) 02/2022
1	Urinary Tract Infections (Urinary Tract Infection) 02/2022
1	Pulmonary Embolism 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Severe Acute Respiratory Syndrome 11/2020
1	Obesity 11/2020
1	Neoplasms (Cancer) 08/2019
1	Proteinuria 12/2015
1	Renal Insufficiency (Renal Failure) 02/2015
1	Lipodystrophy 08/2014
1	Invasive Fungal Infections 12/2010
1	Systemic candidiasis 03/2007
1	Fungemia 07/2006
1	Opportunistic Infections (Opportunistic Infection) 01/2006
1	Cryptococcosis 09/2004

Drug/Important Bio-Agent (IBA)

6	Amphotericin B (Amphotericin)FDA LinkGeneric 11/2013 - 02/2003
4	Pharmaceutical PreparationsIBA 10/2021 - 01/2007
4	Fluconazole (Zonal)FDA LinkGeneric 12/2017 - 12/2002
4	Caspofungin (Cancidas)FDA Link 09/2012 - 10/2004
4	posaconazole FDA Link 10/2010 - 02/2003
3	Micafungin (FK463)FDA Link 01/2016 - 03/2012
2	remdesivirIBA 12/2021 - 11/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 12/2021 - 10/2016
2	Antifungal AgentsIBA 09/2021 - 01/2006
2	CreatinineIBA 11/2020 - 12/2015
2	Anidulafungin FDA Link 03/2012 - 09/2009
1	CephalosporinaseIBA 02/2022
1	ceftazidime drug combination avibactamIBA 02/2022
1	CefiderocolIBA 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	ProdrugsIBA 11/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020
1	C-Reactive ProteinIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	carbapenemaseIBA 07/2019
1	liposomal amphotericin B FDA Link 01/2016
1	Alkaline PhosphataseIBA 12/2015
1	Phosphates (Orthophosphate)IBA 12/2015
1	Therapeutic UsesIBA 09/2012
1	EchinocandinsIBA 03/2012
1	Lysine (L-Lysine)FDA Link 12/2010
1	EnzymesIBA 12/2010
1	homocitrate synthaseIBA 12/2010
1	temporinIBA 01/2006
1	OmigananIBA 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2006
1	Uperoleia mjobergii uperin 3.6 peptideIBA 01/2006
1	antimicrobial peptide IB-367 (iseganan)IBA 01/2006
1	Peptides (Polypeptides)IBA 01/2006
1	pexigananIBA 01/2006
1	Itraconazole (Sporanox)FDA LinkGeneric 02/2003
1	Flucytosine (Ancobon)FDA Link 02/2003
1	TriazolesIBA 12/2002

Therapy/Procedure

11	Therapeutics 01/2021 - 12/2002
4	Artificial Respiration (Mechanical Ventilation) 02/2022 - 11/2020
2	Central Venous Catheters 08/2019 - 07/2006
2	Liver Transplantation 10/2016 - 02/2015
2	Transplantation 10/2016 - 02/2015
2	Intravenous Injections 11/2004 - 09/2004
1	Organ Transplantation 02/2022
1	Operative Surgical Procedures 11/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2016
1	Secondary Prevention 01/2016
1	Drug Therapy (Chemotherapy) 12/2010
1	Catheters 07/2006